Alessandro Santin, MD
Enriched profileProfessor of Obstetrics, Gynecology, and Reproductive Sciences · Yale University
Alessandro Santin is Professor of Obstetrics, Gynecology, and Reproductive Sciences at Yale University. OpenAlex indexes 706 publications with 20,708 citations (h-index 71); ClinicalTrials.gov lists 14 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Gynecologic Oncology profiles in the findmyKOL directory.
Data verified 16 Oct 2026
Overview
Updated 16 Oct 2026
Alessandro Santin, MD, is Professor of Obstetrics, Gynecology, and Reproductive Sciences at Yale University. The public record shows 706 publications with 20,708 citations (h-index 71), centered on Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, HER2/EGFR in Cancer Research. It also documents an investigator role on 14 registered clinical trials, industry payments reported by 14 companies, 3 NIH-funded awards (2008–2018).
- Most recent indexed publication: 2026 · International journal of molecular sciences
- Top research focus: Ovarian cancer diagnosis and treatment
- 14 registered trials on ClinicalTrials.gov
- Open Payments reporting from 14 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 36 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 301.
Clinical & industry
trials, payments and federal fundingContact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 14 registered studies on ClinicalTrials.gov. The most recent:
- A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients
Sponsor: Yale University
Industry payments
Updated 16 Oct 2026
14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202513 payments$24,958openpaymentsdata.cms.gov ↗
- AstraZeneca UK LimitedProgram year20252 payments
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
NIH funding
Updated 16 Oct 2026
3 NIH research awards on record, funded 2008–2018 per NIH RePORTER. The latest:
- Integrated genomic analysis of racial disparities in endometrial cancer
Yale University
FY2018$347,588U01CA176067 - Integrated genomic analysis of racial disparities in endometrial cancer
Yale University
FY2017$348,353U01CA176067 - Integrated genomic analysis of racial disparities in endometrial cancer
Yale University
FY2016$348,353U01CA176067
Congress activity
Updated 16 Oct 2026
60 congress contributions (2009–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Abstract 3397: Modeling cervical cancer heterogeneity using patient-derived organoids for precision treatment development
AACR Annual Meeting
AACR2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Whole-Exome Sequencing Identifies Candidate Genomic Features Associated with Response to Platinum-Based Chemotherapy and Ixabepilone-Based Treatment in Ovarian Cancer.
International journal of molecular sciences
Article2026 - A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.
Clinical cancer research
Clinical Trial2026 - Reply to Hojný et al.: Fusion-driven vs. fusion-negative high-grade endometrial stromal sarcoma.
Proceedings of the National Academy of Sciences of the United States of America
Article2026 - Integrated mutational landscape analysis of endometrial stromal sarcoma.
Proceedings of the National Academy of Sciences of the United States of America
Article2026 - Preclinical Efficacy of the Estrogen Receptor Degrader Fulvestrant in Combination with RAF/MEK Clamp Avutometinib and FAK Inhibitor in a Low-Grade Serous Ovarian Cancer Animal Model with Acquired Resistance to Chemotherapy and Aromatase Inhibitor.
International journal of molecular sciences
Article2025
Most-cited works
by citation count (OpenAlex)- 01Lenvatinib plus Pembrolizumab for Advanced Endometrial CancerArticle930 citations2022
- 02Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast CancerArticle873 citations2019
- 03
- 04
- 05
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/alessandro-santin-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Editorial & leadership roles
journal and society appointments- Co-Chief
Section of Gynecologic Oncology, Yale
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗ - Member
Society of Gynecologic Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗ - Member
International Gynecologic Cancer Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗ - Member
American Association for Cancer Research
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗ - Member
American Society of Clinical Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- Award for Translational Science
Italian Society of Gynecologic Oncologists
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Secondary affiliations
appointments beyond the home institution- Clinical Research Team Leader
Gynecologic Oncology, Yale Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
John Krystal, MD
Yale University
Lajos Pusztai, MD
Yale University
Lee Schwamm, MD
Yale University
Naftali Kaminski, MD
Yale University
Baha Sibai, MD
McGovern Medical School at UTHealth Houston
Robert Coleman, MD
Vaniam Group
Kathleen Moore, MD
University of Nebraska Medical Center
Bradley Monk, MD
Florida Cancer Specialists & Research Institute